GZR4 not checked

Gan & Lee

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
8 active
13 in total · 1 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Diabetes (5 trials), Type 2 Diabetes (2 trials), T2D
Main trialPhase 3
“This study will be conducted to compare the efficacy, safety and patient-reported outcome of once-weekly GZR4 and once-daily Insulin Degludec with or without Non-Insulin Antidiabetic Agents in subjects with Type 2 Diabetes Mellitus (T2DM) treated with basal insulin.”In the company’s words, NCT06767748 on ClinicalTrials.gov
Other names
Degludec · Icodec

Other drugs for Diabetes

All 227 drugs for Diabetes

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials13

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 7 Feb 2026 A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
Phase 3Active, not recruiting 19 Mar 2026 A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin
Phase 3Active, not recruiting 1 Aug 2026 A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)
Phase 3Recruiting 10 Nov 2026 A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
Phase 1Not yet recruiting 30 Sep 2025 A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects
Phase 1Recruiting 1 Apr 2026 Comparison Study of Insulin GZR4 With Insulin Degludec
Phase 1Active, not recruiting 14 Jul 2026 Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment
Phase 1Not yet recruiting 29 Jul 2026 Bioequivalence Study of GZR4 Injection With Different Manufacturing Processes in Healthy Adult Participants
Phase 2Completed 13 Jul 2024 A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus
Phase 1Completed 24 Mar 2023 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4
Phase 1Completed 1 Nov 2023 A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes
Phase 1Completed 20 Aug 2024 Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment
Phase 1Unknown 31 Aug 2024 A Study of GZR4 Injection at Different Injection Sites
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow GZR4

Following is part of Solo: you see every change to GZR4 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in